A detailed history of Community Bank, N.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Community Bank, N.A. holds 51,385 shares of ABBV stock, worth $9.01 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares
51,385
Previous 51,985 1.15%
Holding current value
$9.01 Million
Previous $8.92 Million 13.81%
% of portfolio
1.29%
Previous 1.19%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $98,304 - $119,598
-600 Reduced 1.15%
51,385 $10.1 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $88,230 - $103,033
-570 Reduced 1.08%
51,985 $8.92 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $245,323 - $279,523
-1,535 Reduced 2.84%
52,555 $9.57 Million
Q4 2023

Feb 02, 2024

SELL
$137.6 - $154.97 $241,488 - $271,972
-1,755 Reduced 3.14%
54,090 $8.38 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $4.38 Million - $5.07 Million
-32,775 Reduced 36.98%
55,845 $8.32 Million
Q3 2023

Oct 26, 2023

BUY
$133.59 - $154.65 $4.23 Million - $4.89 Million
31,635 Added 55.51%
88,620 $13.2 Million
Q2 2023

Aug 01, 2023

SELL
$132.51 - $164.9 $109,320 - $136,042
-825 Reduced 1.43%
56,985 $7.68 Million
Q1 2023

Apr 20, 2023

BUY
$144.61 - $166.54 $128,124 - $147,554
886 Added 1.56%
57,810 $9.21 Million
Q4 2022

Jan 31, 2023

BUY
$138.31 - $165.87 $80,496 - $96,536
582 Added 1.03%
56,924 $9.21 Million
Q3 2022

Oct 28, 2022

SELL
$134.21 - $153.93 $18,520 - $21,242
-138 Reduced 0.24%
56,342 $7.56 Million
Q2 2022

Jul 26, 2022

SELL
$137.62 - $174.96 $301,387 - $383,162
-2,190 Reduced 3.73%
56,480 $8.65 Million
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $423,127 - $524,982
-3,206 Reduced 5.18%
58,670 $9.51 Million
Q4 2021

Jan 27, 2022

SELL
$107.43 - $135.93 $27,931 - $35,341
-260 Reduced 0.42%
61,876 $8.38 Million
Q3 2021

Oct 28, 2021

SELL
$106.4 - $120.78 $47,880 - $54,351
-450 Reduced 0.72%
62,136 $6.7 Million
Q2 2021

Aug 03, 2021

SELL
$105.21 - $117.21 $57,339 - $63,879
-545 Reduced 0.86%
62,586 $7.05 Million
Q1 2021

May 04, 2021

SELL
$102.3 - $112.62 $116,622 - $128,386
-1,140 Reduced 1.77%
63,131 $6.83 Million
Q4 2020

Jan 28, 2021

SELL
$80.49 - $108.67 $141,420 - $190,933
-1,757 Reduced 2.66%
64,271 $6.89 Million
Q3 2020

Nov 03, 2020

BUY
$85.91 - $100.83 $101,373 - $118,979
1,180 Added 1.82%
66,028 $5.78 Million
Q2 2020

Jul 30, 2020

SELL
$73.37 - $98.18 $4,402 - $5,890
-60 Reduced 0.09%
64,848 $6.37 Million
Q1 2020

Apr 30, 2020

BUY
$64.5 - $97.79 $28,122 - $42,636
436 Added 0.68%
64,908 $4.95 Million
Q4 2019

Feb 05, 2020

BUY
$72.13 - $90.25 $135,027 - $168,948
1,872 Added 2.99%
64,472 $5.71 Million
Q3 2019

Oct 24, 2019

BUY
$62.98 - $75.72 $27,396 - $32,938
435 Added 0.7%
62,600 $4.74 Million
Q2 2019

Jul 26, 2019

SELL
$65.7 - $83.98 $20,826 - $26,621
-317 Reduced 0.51%
62,165 $4.52 Million
Q1 2019

May 02, 2019

BUY
$77.14 - $90.79 $68,808 - $80,984
892 Added 1.45%
62,482 $5.04 Million
Q4 2018

Jan 30, 2019

BUY
$77.85 - $96.01 $102,761 - $126,733
1,320 Added 2.19%
61,590 $5.68 Million
Q3 2018

Nov 05, 2018

SELL
$88.91 - $98.84 $29,784 - $33,111
-335 Reduced 0.55%
60,270 $5.7 Million
Q2 2018

Jul 12, 2018

SELL
$89.78 - $106.23 $22,893 - $27,088
-255 Reduced 0.42%
60,605 $5.62 Million
Q1 2018

May 03, 2018

SELL
$92.01 - $123.21 $244,010 - $326,752
-2,652 Reduced 4.18%
60,860 $5.76 Million
Q4 2017

Feb 06, 2018

SELL
$89.56 - $98.21 $75,678 - $82,987
-845 Reduced 1.31%
63,512 $6.14 Million
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $4.5 Million - $5.74 Million
64,357
64,357 $5.72 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Community Bank, N.A. Portfolio

Follow Community Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Community Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Community Bank, N.A. with notifications on news.